160 related articles for article (PubMed ID: 32839835)
1. Therapeutic effects of ginsenosides on breast cancer growth and metastasis.
Jin Y; Huynh DTN; Nguyen TLL; Jeon H; Heo KS
Arch Pharm Res; 2020 Aug; 43(8):773-787. PubMed ID: 32839835
[TBL] [Abstract][Full Text] [Related]
2. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
Liu Y; Fan D
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer.
Guo YH; Kuruganti R; Gao Y
Curr Top Med Chem; 2019; 19(25):2334-2347. PubMed ID: 31648643
[TBL] [Abstract][Full Text] [Related]
5. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells.
Song JH; Eum DY; Park SY; Jin YH; Shim JW; Park SJ; Kim MY; Park SJ; Heo K; Choi YJ
PLoS One; 2020; 15(10):e0240533. PubMed ID: 33091036
[TBL] [Abstract][Full Text] [Related]
8. Novel Strategy in Breast Cancer Therapy: Revealing The Bright Side of Ginsenosides.
Hashemi F; Zarrabi A; Zabolian A; Saleki H; Farahani MV; Sharifzadeh SO; Ghahremaniyeh Z; Bejandi AK; Hushmandi K; Ashrafizadeh M; Khan H
Curr Mol Pharmacol; 2021; 14(6):1093-1111. PubMed ID: 33494691
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
11. Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer.
Zhang K; Li Y
Pharm Biol; 2016; 54(4):561-8. PubMed ID: 26511312
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells.
Lee JI; Ha YW; Choi TW; Kim HJ; Kim SM; Jang HJ; Choi JH; Choi MH; Chung BC; Sethi G; Kim SH; Ahn KS; Choi SH; Shim BS; Ahn KS
Planta Med; 2011 Jan; 77(2):133-40. PubMed ID: 20669086
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells.
Xia T; Wang J; Wang Y; Wang Y; Cai J; Wang M; Chen Q; Song J; Yu Z; Huang W; Fang J
Oncotarget; 2016 May; 7(19):27336-49. PubMed ID: 27027340
[TBL] [Abstract][Full Text] [Related]
14. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
16. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
18. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
Liu H; Zhao J; Fu R; Zhu C; Fan D
PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].
Cao M; Yu HS; Song XB; Ma BP
Yao Xue Xue Bao; 2012 Jul; 47(7):836-43. PubMed ID: 22993845
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
